Description
Erlonat 150 mg Erlotinib Tablet provides targeted therapy against cancer. Erlonat 150 mg Erlotinib Tablet belongs to Tyrosine kinase protein inhibitors and is specifically a EGFR inhibitor. Erlonat 150 mg Erlotinib Tablet helps to stop the cancer cells from growing and spreading.
Uses
Treatment of patients who are suffering from metastatic or advanced stage non-small cell lung cancer (NSCLC) and for locally advanced, unresectable or spreading pancreatic cancer, as well.
Side Effects
This is not a full list of all side effects that may occur with this drug. Please seek medical advice from your doctor about if you experience serious side effects and they become overtly bothersome. Also, it is must to talk to your doctor if you see symptoms of easy bleeding tendencies, Jaundice, breathing problems or infections developing in your body.
Drug allergies are quite common and might occur as a result of reaction to active ingredients as well as inactive ingredients. The most common side effects of allergies are: itching, rashes, hives, shortness of breath, low blood pressure, dizziness and loose motions.
Common side effects
- Vomiting/nausea
- Loss of appetite
- Stomatitis
- Dry eyes and dry skin
- Abnormal growth of eyelashes
- Prolonged use may cause kidney problems, internal bleeding in digestive tract, development of Jaundice due to liver damage and tendency to catch infections easily.
Warnings
You must always inform your doctor of pharmacist about your past and present drug allergies or other allergies before taking this medication. Drug allergies to both active ingredients and inactive agents are common.
Before using Erlonat 150 mg Erlotinib Tablet medication, inform your doctor or pharmacist regarding relevant medical history, especially that related to bleeding tendency,heart diseases, lung and liver ailments
